TY - CHAP
T1 - Chemo Brain (Chemo Fog) as a potential side effect of doxorubicin administration
T2 - Role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction
AU - Aluise, Christopher D.
AU - Sultana, Rukhsana
AU - Tangpong, Jitbangjong
AU - Vore, Mary
AU - St. Clair, Daret
AU - Moscow, Jeffrey A.
AU - Butterfield, D. Allan
PY - 2010
Y1 - 2010
N2 - Doxorubicin (ADRIAMYCIN, RUBEX) is a chemotherapeutic agent that is commonly administered to breast cancer patients in standard chemotherapy regimens. As true of all such therapeutic cytotoxic agents, it can damage normal, noncancerous cells and might affect biochemical processes in a manner that might lead to, or contribute to, chemotherapy-induced cognitive deficits when administered either alone or in combination with other agents.
AB - Doxorubicin (ADRIAMYCIN, RUBEX) is a chemotherapeutic agent that is commonly administered to breast cancer patients in standard chemotherapy regimens. As true of all such therapeutic cytotoxic agents, it can damage normal, noncancerous cells and might affect biochemical processes in a manner that might lead to, or contribute to, chemotherapy-induced cognitive deficits when administered either alone or in combination with other agents.
UR - http://www.scopus.com/inward/record.url?scp=77956633238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956633238&partnerID=8YFLogxK
U2 - 10.1007/978-1-4419-6306-2_19
DO - 10.1007/978-1-4419-6306-2_19
M3 - Chapter
C2 - 20738017
AN - SCOPUS:77956633238
SN - 9781441963055
T3 - Advances in Experimental Medicine and Biology
SP - 147
EP - 156
BT - Chemo Fog
A2 - Raffa, Robert
A2 - Tallarida, Ronald
ER -
